{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:38:25Z","timestamp":1783993105319,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"vor","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Health and Medical Research Council (NHMRC)","award":["GNT1011024"],"award-info":[{"award-number":["GNT1011024"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.virol.2016.11.007","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T00:17:44Z","timestamp":1479514664000},"page":"70-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis"],"prefix":"10.1016","volume":"501","author":[{"given":"Danielle","family":"Colledge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Soppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Selleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renae","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Locarnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.virol.2016.11.007_bib1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jvh.12212","article-title":"Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations","volume":"21","author":"Ayres","year":"2014","journal-title":"J. Viral Hepat."},{"issue":"3","key":"10.1016\/j.virol.2016.11.007_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1007117","article-title":"Epidemiology of primary liver cancer","volume":"19","author":"Bosch","year":"1999","journal-title":"Semin. Liver Dis."},{"issue":"5","key":"10.1016\/j.virol.2016.11.007_bib3","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1073\/pnas.87.5.1973","article-title":"Abnormal structure and expression of p53 gene in human hepatocellular carcinoma","volume":"87","author":"Bressac","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.virol.2016.11.007_bib4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jhep.2000.9632","article-title":"Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees","volume":"32","author":"Eren","year":"2000","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.virol.2016.11.007_bib5","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/hep.1840360616","article-title":"Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein","volume":"36","author":"Foo","year":"2002","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.virol.2016.11.007_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00535-007-2085-1","article-title":"Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma","volume":"42","author":"Gao","year":"2007","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.virol.2016.11.007_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/emboj\/21.4.525","article-title":"The preS2 activator MHBs(t) of hepatitis B virus activates c-raf-1\/Erk2 signaling in transgenic mice","volume":"21","author":"Hildt","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2016.11.007_bib8","doi-asserted-by":"crossref","unstructured":"Hildt, E., Hofschneider, P.H., 1998. The preS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Recent Results Cancer Research, vol 154, p. 315\u201329.","DOI":"10.1007\/978-3-642-46870-4_23"},{"issue":"11","key":"10.1016\/j.virol.2016.11.007_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s005350200149","article-title":"Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinoma","volume":"37","author":"Hino","year":"2002","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.virol.2016.11.007_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1872-034X.2009.00582.x","article-title":"Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants","volume":"40","author":"Hosaka","year":"2010","journal-title":"Hepatol. Res."},{"issue":"1","key":"10.1016\/j.virol.2016.11.007_bib11","first-page":"338","article-title":"Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function","volume":"9","author":"Hsieh","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.virol.2016.11.007_bib12","first-page":"265","article-title":"Transactivation by hepatitis B virus may contribute to hepatocarcinogenesis","volume":"144","author":"Koshy","year":"1989","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2016.11.007_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/135965350901400216","article-title":"Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy","volume":"14","author":"Lai","year":"2009","journal-title":"Antivir. Ther."},{"issue":"7","key":"10.1016\/j.virol.2016.11.007_bib14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/135965350801300701","article-title":"The oncogenic potential of hepatitis B virus rtA181T\/ surface truncation mutant","volume":"13","author":"Lai","year":"2008","journal-title":"Antivir. Ther."},{"issue":"2","key":"10.1016\/j.virol.2016.11.007_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12072-012-9411-2","article-title":"Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype","volume":"7","author":"Li","year":"2013","journal-title":"Hepatol. Int."},{"issue":"12","key":"10.1016\/j.virol.2016.11.007_bib16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2217\/fvl.12.113","article-title":"HBV-related hepatocellular carcinoma: the role of integration, viral protiens and miRNA","volume":"7","author":"Lim","year":"2012","journal-title":"Future Virol."},{"issue":"9859","key":"10.1016\/j.virol.2016.11.007_bib17","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global burden of disease study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2016.11.007_bib18","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.07.012","article-title":"HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant","author":"Mason","year":"2016","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.virol.2016.11.007_bib19","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.virol.2016.11.007_bib20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review","volume":"53","author":"Papatheodoridis","year":"2010","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.virol.2016.11.007_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","article-title":"Global cancer statistics in the year 2000","volume":"2","author":"Parkin","year":"2001","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.virol.2016.11.007_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrgastro.2016.7","article-title":"Global strategies are required to cure and eliminate HBV infection","volume":"13","author":"Revill","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8 Pt 1","key":"10.1016\/j.virol.2016.11.007_bib23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1440-1746.2008.05348.x","article-title":"Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection","volume":"23","author":"Su","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.virol.2016.11.007_bib24","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.virol.2016.11.007_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jvh.12380","article-title":"Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection","volume":"22","author":"Tu","year":"2015","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.virol.2016.11.007_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.22295","article-title":"The antiviral drug selected hepatitis B virus rtA181T\/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound","volume":"48","author":"Warner","year":"2008","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.virol.2016.11.007_bib27","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1111\/j.1365-2893.2011.01484.x","article-title":"The hepatitis B e antigen suppresses IL-1beta-mediated NF-kappaB activation in hepatocytes","volume":"18","author":"Wilson","year":"2011","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.virol.2016.11.007_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/jvi.70.1.133-140.1996","article-title":"Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles","volume":"70","author":"Xu","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.007_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/1471-2407-11-398","article-title":"Emergence of the rtA181T\/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B","volume":"11","author":"Yeh","year":"2011","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.virol.2016.11.007_bib30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/infdis\/jiq096","article-title":"Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B","volume":"203","author":"Yeung","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2016.11.007_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2006.11.014","article-title":"SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B","volume":"75","author":"Yuen","year":"2007","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.virol.2016.11.007_bib32","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221630352X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221630352X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:38:57Z","timestamp":1758587937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268221630352X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":32,"alternative-id":["S004268221630352X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2016.11.007","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2016.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}